| JAK/STAT3-regulated fatty acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance T Wang, JF Fahrmann, H Lee, YJ Li, SC Tripathi, C Yue, C Zhang, ... Cell metabolism 27 (1), 136-150. e5, 2018 | 667 | 2018 |
| Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer E Soto-Perez-de-Celis, D Li, Y Yuan, YM Lau, A Hurria The Lancet Oncology 19 (6), e305-e316, 2018 | 337 | 2018 |
| Early diagnostic value of survivin and its alternative splice variants in breast cancer S Khan, HF Bennit, D Turay, M Perez, S Mirshahidi, Y Yuan, NR Wall BMC cancer 14, 1-10, 2014 | 227 | 2014 |
| Rapid targeted next-generation sequencing platform for molecular screening and clinical genotyping in subjects with hemoglobinopathies X Shang, Z Peng, Y Ye, X Zhang, Y Chen, B Zhu, W Cai, S Chen, R Cai, ... EBioMedicine 23, 150-159, 2017 | 153 | 2017 |
| Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP Y Yuan, YM Liao, CT Hsueh, HR Mirshahidi Journal of hematology & oncology 4, 1-14, 2011 | 139 | 2011 |
| Neoadjuvant treatment for triple negative breast cancer: recent progresses and challenges JS Lee, SE Yost, Y Yuan Cancers 12 (6), 1404, 2020 | 108 | 2020 |
| Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients CA Egelston, C Avalos, TY Tu, A Rosario, R Wang, S Solomon, ... JCI insight 4 (19), 2019 | 93 | 2019 |
| Comprehensive profiling of poor-risk paired primary and recurrent triple-negative breast cancers reveals immune phenotype shifts KE Hutchinson, SE Yost, CW Chang, RM Johnson, AR Carr, PR McAdam, ... Clinical Cancer Research 26 (3), 657-668, 2020 | 86 | 2020 |
| Eribulin plus pembrolizumab in patients with metastatic triple-negative breast cancer (ENHANCE 1): a phase Ib/II study SM Tolaney, K Kalinsky, VG Kaklamani, DR D'Adamo, G Aktan, ML Tsai, ... Clinical Cancer Research 27 (11), 3061-3068, 2021 | 81 | 2021 |
| Lipoprotein promotes caveolin-1 and Ras translocation to caveolae: role of cholesterol in endothelial signaling Y Zhu, HL Liao, N Wang, Y Yuan, KS Ma, L Verna, MB Stemerman Arteriosclerosis, thrombosis, and vascular biology 20 (11), 2465-2470, 2000 | 77 | 2000 |
| Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR) Y Zhu, H Liao, X Xie, Y Yuan, TS Lee, N Wang, X Wang, JYJ Shyy, ... Cardiovascular research 68 (3), 425-432, 2005 | 71 | 2005 |
| CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer ZM Zhao, SE Yost, KE Hutchinson, SM Li, YC Yuan, J Noorbakhsh, Z Liu, ... BMC cancer 19, 1-11, 2019 | 66 | 2019 |
| Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers V Chung, FJ Kos, N Hardwick, Y Yuan, J Chao, D Li, J Waisman, M Li, ... Clinical and Translational Oncology 21, 363-372, 2019 | 63 | 2019 |
| Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT). E Soto Perez De Celis, D Li, CL Sun, H Kim, P Twardowski, M Fakih, ... Journal of Clinical Oncology 36 (15_suppl), 10009-10009, 2018 | 61 | 2018 |
| A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor‐positive metastatic triple‐negative breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... The oncologist 26 (2), 99-e217, 2021 | 57 | 2021 |
| Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity YC Ding, L Steele, C Warden, S Wilczynski, J Mortimer, Y Yuan, ... Oncotarget 10 (2), 198, 2019 | 47 | 2019 |
| Letrozole+ ribociclib versus letrozole+ placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial). QJ Khan, A O'Dea, A Bardia, K Kalinsky, KB Wisinski, R O'Regan, Y Yuan, ... Journal of Clinical Oncology 38 (15_suppl), 505-505, 2020 | 46 | 2020 |
| Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment CH Chen, CT Cheng, Y Yuan, J Zhai, M Arif, LWR Fong, R Wu, DK Ann Oncotarget 6 (17), 15194, 2015 | 45 | 2015 |
| Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids YJ Li, JF Fahrmann, M Aftabizadeh, Q Zhao, SC Tripathi, C Zhang, ... Cell reports 39 (9), 2022 | 44 | 2022 |
| Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... European Journal of Cancer 154, 11-20, 2021 | 44 | 2021 |
Daniel SchmolzeCity of Hope Comprehensive Cancer CenterVerified email at coh.org
